Researchers are excited about the medication , a novel dual treatment showing significant outcomes in initial trials for body loss . It functions by targeting several systems: GLP-1 and GIP, that , when https://imogenbpkr741057.tusblogos.com/41393170/this-new-prospect-for-size-reduction